NEW YORK, NY
Allocation by class
Portfolio Concentration
Top 3 weight
40.8%
Top 10 weight
72.8%
Voting Authority Distribution
Total shares with voting rights: 417.26M
Full voting authority
417.26M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Incyte CorporationSOLE | COM | 30.76M | SH | $3.49B 17.48% | 30.76M | 0.00 | 0.00 |
BeOne Medicines Ltd.SOLE | SPONSORED ADS | 8.80M | SH | $2.51B 12.57% | 8.80M | 0.00 | 0.00 |
Revolution Medicines, Inc.SOLE | COM | 11.44M | SH | $2.14B 10.74% | 11.44M | 0.00 | 0.00 |
Madrigal Pharmaceuticals, Inc.SOLE | COM | 2.14M | SH | $1.15B 5.77% | 2.14M | 0.00 | 0.00 |
ACADIA Pharmaceuticals Inc.SOLE | COM | 42.91M | SH | $1.09B 5.44% | 42.91M | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | COM | 8.66M | SH | $992.73M 4.97% | 8.66M | 0.00 | 0.00 |
Insmed IncorporatedSOLE | COM PAR $.01 | 8.80M | SH | $937.84M 4.70% | 8.80M | 0.00 | 0.00 |
Celcuity Inc.SOLE | COM | 7.92M | SH | $828.15M 4.15% | 7.92M | 0.00 | 0.00 |
Kodiak Sciences Inc.SOLE | COM | 19.92M | SH | $776.05M 3.89% | 19.92M | 0.00 | 0.00 |
Rhythm Pharmaceuticals, Inc.SOLE | COM | 5.60M | SH | $622.27M 3.12% | 5.60M | 0.00 | 0.00 |
Praxis Precision Medicines, Inc.SOLE | COM | 1.75M | SH | $586.95M 2.94% | 1.75M | 0.00 | 0.00 |
Alkermes plcSOLE | SHS | 10.01M | SH | $524.59M 2.63% | 10.01M | 0.00 | 0.00 |
Summit Therapeutics Inc.SOLE | COM | 32.79M | SH | $477.70M 2.39% | 32.79M | 0.00 | 0.00 |
GRAIL, Inc.SOLE | COM | 4.03M | SH | $275.03M 1.38% | 4.03M | 0.00 | 0.00 |
AbCellera Biologics Inc.SOLE | COM | 33.01M | SH | $259.15M 1.30% | 33.01M | 0.00 | 0.00 |
Immunovant, Inc.SOLE | COM | 5.44M | SH | $209.42M 1.05% | 5.44M | 0.00 | 0.00 |
IDEAYA Biosciences, Inc.SOLE | COM | 5.01M | SH | $186.72M 0.94% | 5.01M | 0.00 | 0.00 |
Kiniksa Pharmaceuticals International, plcSOLE | ORD SHS CL A | 2.83M | SH | $181.28M 0.91% | 2.83M | 0.00 | 0.00 |
Roivant Sciences Ltd.SOLE | SHS | 4.72M | SH | $166.93M 0.84% | 4.72M | 0.00 | 0.00 |
Arrowhead Pharmaceuticals, Inc.SOLE | COM | 1.99M | SH | $162.43M 0.81% | 1.99M | 0.00 | 0.00 |
Ionis Pharmaceuticals, Inc.SOLE | COM | 2.05M | SH | $162.36M 0.81% | 2.05M | 0.00 | 0.00 |
Edgewise Therapeutics, Inc.SOLE | COM | 3.70M | SH | $150.40M 0.75% | 3.70M | 0.00 | 0.00 |
Replimune Group, Inc.SOLE | COM | 11.05M | SH | $122.27M 0.61% | 11.05M | 0.00 | 0.00 |
Nurix Therapeutics, Inc.SOLE | COM | 4.66M | SH | $113.02M 0.57% | 4.66M | 0.00 | 0.00 |
Stoke Therapeutics, Inc.SOLE | COM | 3.34M | SH | $109.18M 0.55% | 3.34M | 0.00 | 0.00 |